Inmunotek S.L. — Sponsor Intelligence | 19 EU Trials

Filter these 19 trials by condition, phase, country and more.

Open in Search →

19 Registered trials

6 Recruiting

8 Completed trials

4 Countries active

51 Unique IMPs

100% Results reported

Phase III

Phase II

Phase III: 13 Phase II/III: 1 Phase II: 4 Phase I/II: 1

100%

8 of 8 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Allergy test 3 Allergy test positive 3

Top IMPs

HISTAMINE DIHYDROCHLORIDE 7 SODIUM CHLORIDE 6 AZELASTINE HYDROCHLORIDE 2 BETULA PENDULA POLLEN ALLERGOID, MANNAN-CONJUGATED, POLYMERISED 2 BILASTINE 2 BUDESONIDE 2 CAT EPITHELIA 2 CETIRIZINE DIHYDROCHLORIDE 2 CICLESONIDE 2 DERMATOPHAGOIDES PTERONYSSINUS 2 DERMATOPHAGOIDES PTERONYSSINUS ENRICHED ALLERGOID, MANNAN-CONJUGATED, POLYMERISED, DERMATOPHAGOIDES FARINAE ENRICHED ALLERGOID, MANNAN-CONJUGATED, POLYMERISED 2 DESLORATADINE 2

All trials

19 total

D. pteronyssinus and D. farinae allergen extracts. Study of the sensitivity and specificity of the prick test diagnostic preparation Pending

2025-522469-31-00 Phase III 1 country DERMATOPHAGOIDES FARINAE EXTRACT; DERMATOPHAGOIDES PTERONYSSINUS EXTRACT; HISTAM…
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Lepidoglyphus destructor allergy. Pending

2025-522771-28-00 Phase III 1 country DERMATOPHAGOIDES FARINAE ALLERGOID, GLUTARALDEHYDE-MODIFIED, DERMATOPHAGOIDES PT…
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Blomia tropicalis allergy. Pending

2025-522773-12-00 Phase III 1 country DERMATOPHAGOIDES FARINAE ALLERGOID, GLUTARALDEHYDE-MODIFIED, DERMATOPHAGOIDES PT…
Allergen extract of Lepidoglyphus destructor. Study of the sensitivity and specificity of the diagnostic preparation in prick tests Pending

2025-523426-40-00 Phase III 1 country HISTAMINE DIHYDROCHLORIDE; LEPIDOGLYPHUS DESTRUCTOR EXTRACT; SODIUM CHLORIDE
Trial to confirm efficacy, safety, and clinical impact between the bacterial mucosal immunotherapy compared with placebo in women with local… Pending

2025-524377-16-00 Phase III 1 country KLEBSIELLA PNEUMONIAE, STRAIN V113, INACTIVATED, ESCHERICHIA COLI, STRAIN V121, …
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of… Recruiting

2023-508547-51-00 Phase III 2 countries DERMATOPHAGOIDES PTERONYSSINUS ENRICHED ALLERGOID, MANNAN-CONJUGATED, POLYMERISE…
Multicenter clinical trial to evaluate efficacy and safety of sublingual immunotherapy in patients allergic to house mites, with rhinitis/rh… Recruiting

2023-505918-14-00 Phase III 2 countries DERMATOPHAGOIDES FARINAE EXTRACT, DERMATOPHAGOIDES PTERONYSSINUS EXTRACT
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Phase II/III 1 country ALTERNARIA ALTERNATA; AZELASTINE HYDROCHLORIDE; BILASTINE; BUDESONIDE; CAT EPITH…
Phase III clinical trial to evaluate the efficacy and safety of specific immunotherapy with mannanconjugated allergoids for the treatment of… Recruiting

2023-508548-23-00 Phase III 2 countries DERMATOPHAGOIDES PTERONYSSINUS ENRICHED ALLERGOID, MANNAN-CONJUGATED, POLYMERISE…
Study to evaluate the ability of a sublingual vaccine to induce the expression of trained immunity in peripheral blood cells Recruiting

2024-516720-34-00 Phase I/II 1 country
Clinical trial to asses the efficacy and safety of a vaccine for grasses and cupressaceae allergy Recruiting

2024-514524-16-00 Phase III 1 country ALLERGENIC EXTRACT OF JUNIPERUS OXYCEDRUS POLLEN POLYMERIZED WITH GLUTARALDEHYDE…
Clinical trial to assess the efficacy and safety of a vaccine for grasses and olive tree allergy Ended

2024-514525-34-00 Phase III 1 country ALLERGENIC EXTRACT OF OLEA EUROPAEA POLLEN POLYMERIZED WITH GLUTARALDEHYDE, ALLE…
Determination of Blomia tropicalis allergen extract in prick test units Ended

2024-515169-33-00 Phase II 1 country BLOMIA TROPICALIS EXTRACT; HISTAMINE DIHYDROCHLORIDE; SODIUM CHLORIDE
Phleum pratense and Dactylis glomerata allergen extracts. Determination of the in vivo histamine equivalent prick test units. Ended

2024-514215-98-00 Phase II 1 country DACTYLIS GLOMERATA POLLEN EXTRACT, ENRICHED; HISTAMINE DIHYDROCHLORIDE; PHLEUM P…
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 Phase III 1 country AZELASTINE HYDROCHLORIDE; BETULA PENDULA POLLEN ALLERGOID, MANNAN-CONJUGATED, PO…
Lepidoglyphus destructor extract. Determination of in vivo allergenic potency in histamine equivalent prick testing units (HEP). Ended

2023-509541-13-00 Phase II 1 country HISTAMINE DIHYDROCHLORIDE; LEPIDOGLYPHUS DESTRUCTOR EXTRACT; SODIUM CHLORIDE
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered sub… Ended

2023-508013-16-00 Phase III 2 countries BETULA PENDULA POLLEN ALLERGOID, MANNAN-CONJUGATED, POLYMERISED
Quercus ilex and Quercus robur allergen extracts. Determination of in the vivo histamine equivalent prick test units (HEP). Ended

2024-515189-14-00 Phase II 1 country HISTAMINE HYDROCHLORIDE; QUERCUS ILEX ALLERGEN EXTRACT; QUERCUS ROBUR POLLEN EXT…
Clinical trial to assess the efficacy and safety of a vaccine for dust mite allergy Ended

2024-514090-21-00 Phase III 1 country DERMATOPHAGOIDES FARINAE ALLERGOID, GLUTARALDEHYDE-MODIFIED, DERMATOPHAGOIDES PT…

Showing 1–19 of 19 trials

← All sponsors A–Z